Integrated sample preparation and real-time PCR assay for the quantitation of E. coli host cell DNA.
-
Highly sensitive quantitation using proven TaqMan® real-time qPCR technology (Figure 1)
-
Manual and automated sample preparation, optimized for quantitative recovery from complex sample matrices (Table 1)
-
Enables consistent performance across the expected range of DNA fragment sizes (Figure 2)
-
Integrated system from sample to results with sample preparation, master mix, TaqMan® primer/probe mix, and genomic DNA standard
To learn more, click here >>
|
|
|
|
|
|
|
|
|
|
Novartis Phase III study showed 62% of patients with most severe form of childhood arthritis were symptom-free with ACZ885 treatment
|
|
Novartis has announced new data from two trials with ACZ885 (canakinumab); a pivotal Phase III study in patients with systemic juvenile idiopathic arthritis (SJIA), and a Phase II study in patients with tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS).
SJIA and TRAPS are both rare and serious autoinflammatory diseases that usually start in childhood...
Read full story >>
|
|
 |
|
|
|
|
|
|
|
Interphex 2012 - Exclusive video interviews
|
|
Conferences, events & exhibitions:
Life Science User Group
7 June 2012, San Juan, Puerto Rico
BPS Focused Meeting on Neuropeptides
7 - 9 June 2012, London, UK
13th Drug Discovery Summit 2012
11 - 12 June 2012, Zurich, Switzerland
Pharma R&D Europe Summits
11 - 12 June 2012, Zurich, Switzerland
2. Laupheimer Zelltage
11 - 12 June 2012, Laupheim, Germany
Life Science User Group
12 June 2012, Missouri, USA
ISSCR 2012
13 - 16 June 2012, Yokohama, Japan
Life Science User Group
14 June 2012, Indiana, USA
|
|
|
